|
|
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
Ra Pharmaceuticals, Inc. (RARX) |
|
|
$46.96 0.00 (0.00%) as of 4:30 Thu 3/19
|
|
Download |
|
|
Company
Roster
|
Total
Insiders : |
24 |
|
|
Total
Direct Shares :
|
16,009,011 |
|
Total
Indirect Shares :
|
35,477,160 |
|
%
Held by Insiders:
|
33.95% |
|
|
|
Filer's Name |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Bisgaard Peter |
|
|
0 |
|
0 |
Heft Robert |
|
|
0 |
|
0 |
Lettmann Jason |
Director |
|
0 |
2016-10-31 |
4,066,503 |
Barris Peter J |
10% Owner |
2016-10-31 |
0 |
2016-10-31 |
3,490,073 |
Mott David M |
10% Owner |
2016-10-31 |
0 |
2016-10-31 |
3,490,073 |
Weller Harry R |
10% Owner |
2016-10-31 |
0 |
2016-10-31 |
3,490,073 |
Baskett Forest |
10% Owner |
2016-10-31 |
0 |
2016-10-31 |
3,490,073 |
Novo A/s |
10% Owner |
2016-10-31 |
2,031,562 |
2016-10-31 |
0 |
Barrett M James |
10% Owner |
2016-10-31 |
0 |
2016-10-31 |
3,490,073 |
Kerins Patrick J |
10% Owner |
2016-10-31 |
0 |
2016-10-31 |
3,490,073 |
Morgenthaler Management Partners Ix, Llc |
10% Owner |
2016-10-31 |
2,745,846 |
|
0 |
Shah Rajeev M. |
Director, 10% Owner |
2016-10-31 |
0 |
2020-04-02 |
0 |
Kolluri Krishna Kittu |
10% Owner |
2016-10-31 |
0 |
2016-10-31 |
3,490,073 |
Nea 13 Gp, Ltd |
10% Owner |
2016-10-31 |
3,490,073 |
2016-10-31 |
0 |
Kolchinsky Peter |
Director, 10% Owner |
2016-10-31 |
0 |
2020-04-02 |
0 |
Novartis Ag |
10% Owner |
2017-06-19 |
2,251,457 |
2016-10-31 |
0 |
Viswanathan Ravi |
10% Owner |
2018-02-16 |
5,490,073 |
2016-10-31 |
3,490,073 |
Read Simon |
Chief Scientific Officer |
2020-04-02 |
0 |
2019-02-01 |
0 |
Sandell Scott D |
10% Owner |
2020-04-02 |
0 |
2016-10-31 |
3,490,073 |
Ricardo Alonso |
See Remarks |
2020-04-02 |
0 |
|
0 |
Treco Douglas A |
President and CEO, Director |
2020-04-02 |
0 |
|
0 |
Lubner David Charles |
Executive VP and CFO |
2020-04-02 |
0 |
2019-02-01 |
0 |
Farzaneh-Far Ramin |
Chief Medical Officer |
2020-04-02 |
0 |
2019-02-01 |
0 |
King John C |
Chief Commercial Officer |
2020-04-02 |
0 |
2019-04-16 |
0 |
|
|